SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
GE Vernova Inc. (GEV) trades at a trailing P/E of 52.7, forward P/E of 67.1. Trailing earnings yield is 1.90%, forward earnings yield 1.49%. PEG 0.24 (Peter Lynch undervalued ≤1.0). Graham Number is $135.14.
Criteria proven by this page:
- VALUE (60/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.24).
- PEG Ratio 0.24 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.90% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
- Analyst consensus target $840.29 (-14.9% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 61/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GEV
Valuation Multiples
P/E (TTM)52.7
Forward P/E67.1
PEG Ratio0.24
Forward PEG1.85
P/B Ratio23.01
P/S Ratio6.69
EV/EBITDA66.8
Per Share Data
EPS (TTM)$17.96
Forward EPS (Est.)$14.71
Book Value / Share$45.20
Revenue / Share$139.99
FCF / Share$13.64
Yields & Fair Value
Earnings Yield1.90%
Forward Earnings Yield1.49%
Dividend Yield0.16%
Graham Number$135.14
SharesGrow IV$58.33 (-94.1%)
Analyst Target$840.29 (-14.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2021 |
-56.4 |
0.00 |
0.00 |
1.08 |
- |
| 2022 |
-13.1 |
-0.04 |
3.35 |
1.20 |
- |
| 2023 |
-81.5 |
0.97 |
4.82 |
1.07 |
- |
| 2024 |
58.3 |
-0.13 |
9.48 |
2.59 |
0.08% |
| 2025 |
36.4 |
0.17 |
15.90 |
4.67 |
0.15% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2021 |
$-2.33 |
$33.01B |
$-633M |
-1.9% |
| 2022 |
$-10.06 |
$29.65B |
$-2.74B |
-9.2% |
| 2023 |
$-1.98 |
$33.24B |
$-438M |
-1.3% |
| 2024 |
$5.58 |
$34.94B |
$1.55B |
4.4% |
| 2025 |
$17.69 |
$38.07B |
$4.88B |
12.8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$14.67 |
$12.37 – $16.09 |
$44.62B |
$43.95B – $45.36B |
21 |
| 2027 |
$22.51 |
$20.52 – $25.38 |
$50.65B |
$49.11B – $53.25B |
20 |
| 2028 |
$31.47 |
$20.46 – $46.11 |
$57.52B |
$57.31B – $57.72B |
21 |
| 2029 |
$41.13 |
$38.23 – $43.80 |
$65.95B |
$62.37B – $69.24B |
9 |
| 2030 |
$49.51 |
$46.01 – $52.72 |
$72.26B |
$68.33B – $75.86B |
9 |
